000 | 03002 a2200841 4500 | ||
---|---|---|---|
005 | 20250517070118.0 | ||
264 | 0 | _c20160628 | |
008 | 201606s 0 0 eng d | ||
022 | _a1474-5488 | ||
024 | 7 |
_a10.1016/S1470-2045(15)00465-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChanan-Khan, Asher | |
245 | 0 | 0 |
_aIbrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study. _h[electronic resource] |
260 |
_bThe Lancet. Oncology _cFeb 2016 |
||
300 |
_a200-211 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenine _xanalogs & derivatives |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAnemia _xchemically induced |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
650 | 0 | 4 |
_aAtrial Fibrillation _xchemically induced |
650 | 0 | 4 |
_aBendamustine Hydrochloride _xadministration & dosage |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHemorrhage _xchemically induced |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIntention to Treat Analysis |
650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNausea _xchemically induced |
650 | 0 | 4 |
_aNeutropenia _xchemically induced |
650 | 0 | 4 | _aPiperidines |
650 | 0 | 4 |
_aPyrazoles _xadministration & dosage |
650 | 0 | 4 |
_aPyrimidines _xadministration & dosage |
650 | 0 | 4 | _aRetreatment |
650 | 0 | 4 |
_aRituximab _xadministration & dosage |
650 | 0 | 4 |
_aThrombocytopenia _xchemically induced |
700 | 1 | _aCramer, Paula | |
700 | 1 | _aDemirkan, Fatih | |
700 | 1 | _aFraser, Graeme | |
700 | 1 | _aSilva, Rodrigo Santucci | |
700 | 1 | _aGrosicki, Sebastian | |
700 | 1 | _aPristupa, Aleksander | |
700 | 1 | _aJanssens, Ann | |
700 | 1 | _aMayer, Jiri | |
700 | 1 | _aBartlett, Nancy L | |
700 | 1 | _aDilhuydy, Marie-Sarah | |
700 | 1 | _aPylypenko, Halyna | |
700 | 1 | _aLoscertales, Javier | |
700 | 1 | _aAvigdor, Abraham | |
700 | 1 | _aRule, Simon | |
700 | 1 | _aVilla, Diego | |
700 | 1 | _aSamoilova, Olga | |
700 | 1 | _aPanagiotidis, Panagiots | |
700 | 1 | _aGoy, Andre | |
700 | 1 | _aMato, Anthony | |
700 | 1 | _aPavlovsky, Miguel A | |
700 | 1 | _aKarlsson, Claes | |
700 | 1 | _aMahler, Michelle | |
700 | 1 | _aSalman, Mariya | |
700 | 1 | _aSun, Steven | |
700 | 1 | _aPhelps, Charles | |
700 | 1 | _aBalasubramanian, Sriram | |
700 | 1 | _aHowes, Angela | |
700 | 1 | _aHallek, Michael | |
773 | 0 |
_tThe Lancet. Oncology _gvol. 17 _gno. 2 _gp. 200-211 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1470-2045(15)00465-9 _zAvailable from publisher's website |
999 |
_c25530785 _d25530785 |